Written by The Lancet Market is gaining momentum as healthcare systems increasingly emphasize early disease detection and decentralized testing. Rising diabetes prevalence is particularly important because regular blood-glucose monitoring requires frequent capillary sampling. The market is forecast to increase from USD 2.05 billion in 2025 to USD 4.34 billion by 2035.
Product innovation is transforming the lancet industry, with manufacturers focusing on safer and less painful blood-collection solutions. Microneedle technologies and automated safety mechanisms are being explored to improve the patient experience and reduce discomfort. These developments may encourage greater adherence among people who require frequent self-testing.
Glucose testing remains the leading application, accounting for about 86% of market share in 2025. Hemoglobin testing is another important application and is projected to expand at a 7.6% CAGR through 2035, supported by anemia screening programs and increased access to decentralized diagnostics.
North America currently leads the global market, while Asia-Pacific is growing at the fastest rate. Expansion of healthcare screening programs, increasing self-monitoring, insurance coverage, and point-of-care testing are expected to create new opportunities. At the same time, non-invasive glucose monitoring and environmental concerns related to single-use plastics may influence future product development.
Dive into related studies for a broader industry perspective:
Pet Healthcare Product Market Volume
Pet Healthcare Product Market Forecast
Pet Healthcare Product Market Outlook